Although high serum levels of insulin, leptin and estradiol have been proposed to activate diverse signaling cascades and contribute to the progression of postmenopausal breast cancer of patients with obesity [4, 11], however, the molecular mechanisms by which obesity correlates with premenopausal breast cancer remain to be unraveled. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.